CANCER PROGRESSION AND TUMOR CELL MOTILITY
|
phenotype |
|
Finding
|
1
|
1
|
0.100 |
None |
|
0 |
1
|
|
|
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Diffuse Astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
81
|
8
|
0.010 |
None |
< 0.001 |
1 |
|
2002 |
2002 |
polyps
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Anatomical Abnormality
|
390
|
18
|
0.010 |
None |
< 0.001 |
1 |
|
2012 |
2012 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
< 0.001 |
1 |
|
2006 |
2006 |
Malignant Pleural Mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
421
|
15
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Cerebrovascular accident
|
group |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1658
|
591
|
0.010 |
None |
< 0.001 |
1 |
2
|
2014 |
2014 |
invasive cancer
|
phenotype |
Neoplasms
|
Neoplastic Process
|
146
|
15
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Peritoneal dissemination
|
disease |
|
Neoplastic Process
|
170
|
|
0.010 |
None |
< 0.001 |
1 |
|
2018 |
2018 |
Eclampsia
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
241
|
38
|
0.010 |
None |
< 0.001 |
1 |
1
|
2011 |
2011 |
Glioblastoma Multiforme
|
disease |
Neoplasms
|
Neoplastic Process
|
3197
|
186
|
0.030 |
None |
0.333 |
3 |
|
2002 |
2011 |
Hepatocarcinogenesis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
855
|
24
|
0.020 |
None |
0.500 |
2 |
|
2017 |
2019 |
Malignant neoplasm of ovary
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2563
|
315
|
0.020 |
None |
0.500 |
2 |
|
2013 |
2015 |
Squamous cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
670
|
283
|
0.020 |
None |
0.500 |
2 |
|
2016 |
2017 |
Alveolar rhabdomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
115
|
1
|
0.020 |
None |
0.500 |
2 |
|
2012 |
2012 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.020 |
None |
0.500 |
2 |
|
2013 |
2015 |
Liver neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1424
|
7
|
0.030 |
None |
0.667 |
3 |
|
2010 |
2019 |
ovarian neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2542
|
757
|
0.040 |
None |
0.750 |
4 |
|
1993 |
2015 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.060 |
None |
0.833 |
6 |
1
|
2007 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.923 |
13 |
1
|
1993 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.100 |
None |
0.929 |
14 |
2
|
2004 |
2016 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.600 |
None |
0.929 |
14 |
2
|
2004 |
2016 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.100 |
None |
0.933 |
15 |
1
|
2004 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.942 |
52 |
2
|
1989 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.943 |
35 |
1
|
2000 |
2019 |